144 related articles for article (PubMed ID: 24867525)
21. Altered miRNA and gene expression in acute myeloid leukemia with complex karyotype identify networks of prognostic relevance.
Rücker FG; Russ AC; Cocciardi S; Kett H; Schlenk RF; Botzenhardt U; Langer C; Krauter J; Fröhling S; Schlegelberger B; Ganser A; Lichter P; Zenz T; Döhner H; Döhner K; Bullinger L
Leukemia; 2013 Feb; 27(2):353-61. PubMed ID: 22810507
[TBL] [Abstract][Full Text] [Related]
22. EVI1 overexpression in distinct subtypes of pediatric acute myeloid leukemia.
Balgobind BV; Lugthart S; Hollink IH; Arentsen-Peters ST; van Wering ER; de Graaf SS; Reinhardt D; Creutzig U; Kaspers GJ; de Bont ES; Stary J; Trka J; Zimmermann M; Beverloo HB; Pieters R; Delwel R; Zwaan CM; van den Heuvel-Eibrink MM
Leukemia; 2010 May; 24(5):942-9. PubMed ID: 20357826
[TBL] [Abstract][Full Text] [Related]
23. PP2A impaired activity is a common event in acute myeloid leukemia and its activation by forskolin has a potent anti-leukemic effect.
Cristóbal I; Garcia-Orti L; Cirauqui C; Alonso MM; Calasanz MJ; Odero MD
Leukemia; 2011 Apr; 25(4):606-14. PubMed ID: 21233840
[TBL] [Abstract][Full Text] [Related]
24. Oncogene- and drug resistance-associated alternative exon usage in acute myeloid leukemia (AML).
Mohamed AM; Balsat M; Thenoz M; Koering C; Payen-Gay L; Cheok M; Mortada H; Auboeuf D; Pinatel C; El-Hamri M; Dumontet C; Cros E; Flandrin-Gresta P; Nibourel O; Preudhomme C; Michallet M; Thomas X; Nicolini F; Solly F; Guyotat D; Campos L; Wattel E; Mortreux F
Oncotarget; 2016 Jan; 7(3):2889-909. PubMed ID: 26284582
[TBL] [Abstract][Full Text] [Related]
25. Differential expression of specific microRNA and their targets in acute myeloid leukemia.
Cammarata G; Augugliaro L; Salemi D; Agueli C; La Rosa M; Dagnino L; Civiletto G; Messana F; Marfia A; Bica MG; Cascio L; Floridia PM; Mineo AM; Russo M; Fabbiano F; Santoro A
Am J Hematol; 2010 May; 85(5):331-9. PubMed ID: 20425795
[TBL] [Abstract][Full Text] [Related]
26. Persistent altered fusion transcript splicing identifies RUNX1-RUNX1T1+ AML patients likely to relapse.
Ommen HB; Ostergaard M; Yan M; Braendstrup K; Zhang DE; Hokland P
Eur J Haematol; 2010 Feb; 84(2):128-32. PubMed ID: 19891700
[TBL] [Abstract][Full Text] [Related]
27. Gene expression profiling in the leukemic stem cell-enriched CD34+ fraction identifies target genes that predict prognosis in normal karyotype AML.
de Jonge HJ; Woolthuis CM; Vos AZ; Mulder A; van den Berg E; Kluin PM; van der Weide K; de Bont ES; Huls G; Vellenga E; Schuringa JJ
Leukemia; 2011 Dec; 25(12):1825-33. PubMed ID: 21760593
[TBL] [Abstract][Full Text] [Related]
28. Therapy of acute myeloid leukemia: towards a patient-oriented, risk-adapted approach.
Mandelli F; Petti MC; Lo Coco F
Haematologica; 1998 Nov; 83(11):1015-23. PubMed ID: 9864924
[TBL] [Abstract][Full Text] [Related]
29. Impact of IDH1 R132 mutations and an IDH1 single nucleotide polymorphism in cytogenetically normal acute myeloid leukemia: SNP rs11554137 is an adverse prognostic factor.
Wagner K; Damm F; Göhring G; Görlich K; Heuser M; Schäfer I; Ottmann O; Lübbert M; Heit W; Kanz L; Schlimok G; Raghavachar AA; Fiedler W; Kirchner HH; Brugger W; Zucknick M; Schlegelberger B; Heil G; Ganser A; Krauter J
J Clin Oncol; 2010 May; 28(14):2356-64. PubMed ID: 20368538
[TBL] [Abstract][Full Text] [Related]
30. Aberrant activation of RPB1 is critical for cell overgrowth in acute myeloid leukemia.
Yu Q; Xu Y; Zhuang H; Wu Z; Zhang L; Li J; Yang L; Wu B; Wang P; Zhang X; Gan X; Liang Y; Zheng S; Yu X; Gu Y; Xu R
Exp Cell Res; 2019 Nov; 384(2):111653. PubMed ID: 31574286
[TBL] [Abstract][Full Text] [Related]
31. Splicing factor-mediated regulation patterns reveals biological characteristics and aid in predicting prognosis in acute myeloid leukemia.
Zhong FM; Yao FY; Liu J; Li MY; Jiang JY; Cheng Y; Xu S; Li SQ; Zhang N; Huang B; Wang XZ
J Transl Med; 2023 Jan; 21(1):6. PubMed ID: 36611187
[TBL] [Abstract][Full Text] [Related]
32. TAP: a targeted clinical genomics pipeline for detecting transcript variants using RNA-seq data.
Chiu R; Nip KM; Chu J; Birol I
BMC Med Genomics; 2018 Sep; 11(1):79. PubMed ID: 30200994
[TBL] [Abstract][Full Text] [Related]
33. Two-step mixed model approach to analyzing differential alternative RNA splicing.
Luo L; Kang H; Li X; Ness SA; Stidley CA
PLoS One; 2020; 15(10):e0232646. PubMed ID: 33035235
[TBL] [Abstract][Full Text] [Related]
34. Network-based sub-network signatures unveil the potential for acute myeloid leukemia therapy.
Shi M; Wu M; Pan P; Zhao R
Mol Biosyst; 2014 Dec; 10(12):3290-7. PubMed ID: 25313005
[TBL] [Abstract][Full Text] [Related]
35. Commonly altered genomic regions in acute myeloid leukemia are enriched for somatic mutations involved in chromatin remodeling and splicing.
Dolnik A; Engelmann JC; Scharfenberger-Schmeer M; Mauch J; Kelkenberg-Schade S; Haldemann B; Fries T; Krönke J; Kühn MW; Paschka P; Kayser S; Wolf S; Gaidzik VI; Schlenk RF; Rücker FG; Döhner H; Lottaz C; Döhner K; Bullinger L
Blood; 2012 Nov; 120(18):e83-92. PubMed ID: 22976956
[TBL] [Abstract][Full Text] [Related]
36. RNA Splicing Alterations Induce a Cellular Stress Response Associated with Poor Prognosis in Acute Myeloid Leukemia.
Anande G; Deshpande NP; Mareschal S; Batcha AMN; Hampton HR; Herold T; Lehmann S; Wilkins MR; Wong JWH; Unnikrishnan A; Pimanda JE
Clin Cancer Res; 2020 Jul; 26(14):3597-3607. PubMed ID: 32122925
[TBL] [Abstract][Full Text] [Related]
37. Relation of BAALC and ERG Gene Expression with Overall Survival in Acute Myeloid Leukemia Cases.
Rashed RA; Kadry DY; El Taweel M; Abd El Wahab N; Abd El Hameed T
Asian Pac J Cancer Prev; 2015; 16(17):7875-82. PubMed ID: 26625814
[TBL] [Abstract][Full Text] [Related]
38. Effects of Alternative Splicing Events on Acute Myeloid Leukemia.
Chen SL; Dai YJ; Hu F; Wang Y; Li H; Liang Y
DNA Cell Biol; 2020 Nov; 39(11):2040-2051. PubMed ID: 32915082
[TBL] [Abstract][Full Text] [Related]
39. Chemoresistance in acute myeloid leukemia: An alternative single-cell RNA sequencing approach.
Cheng PL; Hsiao TH; Chen CH; Hung MN; Jhan PP; Lee LW; Wu TS; Tsai JR; Teng CJ
Hematol Oncol; 2023 Aug; 41(3):499-509. PubMed ID: 36790759
[TBL] [Abstract][Full Text] [Related]
40. Prognostic alternative mRNA splicing signatures and associated splicing factors in acute myeloid leukemia.
Jin P; Tan Y; Zhang W; Li J; Wang K
Neoplasia; 2020 Sep; 22(9):447-457. PubMed ID: 32653835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
